Synovir thalidomide: Began Phase I safety trial with the NIH that will examine the effect on viral and immunologic markers correlated with progression of HIV in

Celgene Corp. (CELG), Warren, N.J. Product: Synovir thalidomide, which lowers production of tumor necrosis factor alpha Indication: HIV infection and AIDS Status: Began Phase I safety trial with the...